Epirubicin hydrochloride injection 50 mg in 25 mL (4)

Χώρα: Αυστραλία

Γλώσσα: Αγγλικά

Πηγή: Department of Health (Therapeutic Goods Administration)

Δραστική ουσία:

epirubicin hydrochloride, Quantity: 2 mg/mL

Διαθέσιμο από:

Pfizer (Perth) Pty Ltd

Φαρμακοτεχνική μορφή:

Injection, solution

Σύνθεση:

Excipient Ingredients: sodium chloride; hydrochloric acid; water for injections

Οδός χορήγησης:

Intravenous, Intravesical, Intraarterial

Μονάδες σε πακέτο:

25 mL x 1

Τρόπος διάθεσης:

(S1) This Schedule is intentionally blank

Θεραπευτικές ενδείξεις:

Indications for Chile: Farmorubicin has the ability to induce useful responses in a broad spectrum of neoplastic diseases, such as carcinoma of breast, malignant lymphomas, sarcoma of the soft tissues, gastric carcinoma, carcinoma of the liver, pancreas, sigmoid rectum, cervicofacial carcinoma, lung carcinoma, ovarian carcinoma and leukemia. High doses of Farmorubicin can be used in the treatment of breast cancer. Positive results have been obtained with Farmorubicin administered intravesically in the treatment of superficial bladder tumors, transitional cells (carcinoma in situ), and in the prophylaxis of recurrences after transurethral resection. Indications for Colombia:Treatment of aeute leukemias, malignant lymphomas, soft tissue sarcoma, gastric cancer, liver cancer, pancreatic cancer, rectosigmoid (bowel) cancer, head and neck cancer, lung cancer, ovarian cancer.

Περίληψη προϊόντος:

Visual Identification: Clear and clean red solution.; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Καθεστώς αδειοδότησης:

Listed (Export Only)

Ημερομηνία της άδειας:

2018-09-20